 |
 |
ISRAEL: Three New Drugs Developed at the Technion-Israel Institute of Technology Israel Line 8-Nov-2004 Excess iron that causes the brain to "rust" is the target of three new drugs developed at the Technion-Israel Institute of Technology to treat and prevent neurodegenerative diseases such as Alzheimer's, Parkinson's, and ALS, THE JERUSALEM POST reported. The trio of drugs known as VK-28, HLA-20, and M30, which were recently approved by the U.S. Food and Drug Administration, mop up excess iron before it can trigger a chemical reaction between oxygen free radicals and iron, a hallmark of many neurodegenerative diseases. Unlike other drugs currently used against these disorders, which try to replace the functions lost by dying neurons, these drugs halt the neuron destruction itself. [Today's Israel Line was prepared by Victor Chemtob at the Consulate General of Israel in New York.] SOURCE: Israel Ministry of Foreign Affairs, Israel http://tinyurl.com/6tso3 * * *Murray Charters <[log in to unmask]> Please place this address in your address book Please purge all others Web site: Parkinsons Resources on the WWWeb http://www.geocities.com/murraycharters ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn